MXPA05007826A - Composiciones farmaceuticas en polvo. - Google Patents

Composiciones farmaceuticas en polvo.

Info

Publication number
MXPA05007826A
MXPA05007826A MXPA05007826A MXPA05007826A MXPA05007826A MX PA05007826 A MXPA05007826 A MX PA05007826A MX PA05007826 A MXPA05007826 A MX PA05007826A MX PA05007826 A MXPA05007826 A MX PA05007826A MX PA05007826 A MXPA05007826 A MX PA05007826A
Authority
MX
Mexico
Prior art keywords
pharmaceutical compositions
powder pharmaceutical
flu
powder
symptoms
Prior art date
Application number
MXPA05007826A
Other languages
English (en)
Inventor
Oswaldo David Romero
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MXPA05007826A publication Critical patent/MXPA05007826A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invencion esta dirigida a composiciones farmaceuticas en polvo que son disolubles en un liquido, como por ejemplo, agua caliente, en donde las composiciones brindan un efecto terapeutico en el tratamiento de los sintomas asociados con el resfriado y/o gripe comun; estas composiciones farmaceuticas en polvo comprenden un activo farmaceutico selecto que es especialmente efectivo en aliviar los sintomas del resfriado y/o gripe.
MXPA05007826A 2003-01-23 2004-01-16 Composiciones farmaceuticas en polvo. MXPA05007826A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/349,665 US20040162273A1 (en) 2003-01-23 2003-01-23 Powder pharmaceutical compositions
PCT/US2004/001249 WO2004066978A1 (en) 2003-01-23 2004-01-16 Powder pharmaceutical compositions

Publications (1)

Publication Number Publication Date
MXPA05007826A true MXPA05007826A (es) 2005-10-18

Family

ID=32823699

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05007826A MXPA05007826A (es) 2003-01-23 2004-01-16 Composiciones farmaceuticas en polvo.

Country Status (10)

Country Link
US (1) US20040162273A1 (es)
EP (1) EP1587498A1 (es)
JP (1) JP2006515603A (es)
CN (1) CN1738604A (es)
BR (1) BRPI0406859A (es)
CA (1) CA2509807A1 (es)
MX (1) MXPA05007826A (es)
PL (1) PL378011A1 (es)
RU (1) RU2005123045A (es)
WO (1) WO2004066978A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0307440D0 (en) * 2003-03-31 2003-05-07 Novartis Ag Organic compounds
BRPI0518553A2 (pt) * 2004-12-13 2008-11-25 Mcneil Ppc Inc composiÇço farmacÊutica estÁvel, mÉtodo para estabilizaÇço de pelo menos um ingrediente farmaceuticamente ativo e mÉtodo de uso de celulose microcristalina silicificada
US20070249727A1 (en) 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
US10022339B2 (en) 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US20070254027A1 (en) * 2006-04-28 2007-11-01 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US20080014275A1 (en) * 2006-07-13 2008-01-17 Buehler Gail K Pharmaceutical suspensions and related methods
US20080268025A1 (en) * 2007-04-25 2008-10-30 Donald Spector Compositions Useful for Preventing Pain and Soreness Resulting from Exercise and Methods of Use
WO2009012590A1 (en) * 2007-07-23 2009-01-29 Kingsway Pharmaceuticals Inc. Therapeutic formulations for the treatment of cold and flu-like symptoms
CN104936585B (zh) * 2013-02-04 2017-11-14 Aft制药有限公司 包括苯肾上腺素和扑热息痛的组合药剂
US20140271923A1 (en) 2013-03-14 2014-09-18 Christopher Brian Reid Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions
EP3095466B1 (en) * 2015-05-21 2020-12-16 Abdi Ibrahim Ilac Sanayi ve Ticaret A.S. Pharmaceutical formulations with improved solubility and stability
MX2020012233A (es) 2018-05-16 2021-01-29 Bayer Healthcare Llc Formula de suspension de alta concentracion para medicamentos en capsula de gel blanda para resfriado y gripe.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4260600A (en) * 1979-10-22 1981-04-07 Ronald Valle Method of treating depression
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4631284A (en) * 1984-11-19 1986-12-23 Mallinckrodt, Inc. Acetaminophen compositions containing low doses of chlorpheniramine maleate, method for preparing same and tablets formed therefrom
US4771077A (en) * 1986-10-21 1988-09-13 American Home Products Corporation (Del.) Spray dried acetaminophen
US4975426A (en) * 1987-06-08 1990-12-04 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US5814337A (en) * 1992-10-07 1998-09-29 Beecham Group Plc Pharmaceutical formulation
GB9224021D0 (en) * 1992-11-16 1993-01-06 Boots Co Plc Effervescent compositions
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6462094B1 (en) * 2001-08-22 2002-10-08 Medpointe Healthcare Inc. Decongestant/expectorant compositions

Also Published As

Publication number Publication date
JP2006515603A (ja) 2006-06-01
CN1738604A (zh) 2006-02-22
WO2004066978A8 (en) 2005-03-24
BRPI0406859A (pt) 2006-02-07
EP1587498A1 (en) 2005-10-26
PL378011A1 (pl) 2006-02-20
US20040162273A1 (en) 2004-08-19
WO2004066978A1 (en) 2004-08-12
RU2005123045A (ru) 2006-01-27
CA2509807A1 (en) 2004-08-12

Similar Documents

Publication Publication Date Title
GB0405055D0 (en) JNK inhibitors
GB0108770D0 (en) Inhibitors
GB0516156D0 (en) JNK inhibitors
WO2004078756A3 (en) Jnk inhibitors
MX2009006704A (es) Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa.
MY173994A (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
IL164187A0 (en) 7-Azaindole derivatives and pharmaceutical compositions containing the same
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
IL164082A0 (en) Azaindole derivatives and pharmaceutical compositions containing the same
GB2480773A (en) Compositions and methods for the treatment or the preventation oral infections by E.Coli
IL197080A0 (en) Pyrimidone compounds as gsk-3 inhibitors
MX2010003013A (es) Inhibicion de angiogenesis.
MXPA05007826A (es) Composiciones farmaceuticas en polvo.
ZA200807879B (en) Use of bifidobacterium longum for the prevention and treatment of inflammation
TW200800976A (en) New compounds for the treatment of neurological, psychiatric or pain disorders
SG10201407403UA (en) Treatments For Gastrointestinal Disorders
WO2004101565A3 (en) Jnk inhibitors
EP1858520A4 (en) CALCIUM CHANNEL ANTAGONISTS TYPE CHINAZOLINONE T
MX2009004745A (es) Derivados de 1,2,3-triazol como inhibidores del receptor sigma.
TW200505904A (en) Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
WO2007087151A3 (en) Combination of ache inhibitor and 5-ht6 antagonist for the treatment of cognitive dysfunction
MXPA05011858A (es) Agentes terapeuticos que comprenden un agente antiagiongenico en combinacion con un inhibidor src y su uso terapeutico.
TW200730190A (en) New combination to treat liver fibrosis
TNSN08385A1 (en) Delayed-release glucocorticoid treatment of rheumatoid disease
WO2008100653A3 (en) Copper lowering treatment of cardiac disease